How to start prophylaxis

Haemophilia

Volumn 9, Issue SUPPL. 1, 2003, Pages 83-87

  Petrini, Pia ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Administration and dosage; Clinical protocols; Haemophilia A; Haemophilia B; Prophylaxis

Indexed keywords

BLOOD CLOTTING FACTOR CONCENTRATE; RECOMBINANT BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 9;

ARTHROPATHY; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; COHORT ANALYSIS; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EPIDURAL SPACE; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HOME CARE; HUMAN; INFANT; MALE; MYOPATHY; PERIPHERAL VEIN; PRESCHOOL CHILD; PRIORITY JOURNAL; SYMPTOMATOLOGY; TREATMENT OUTCOME;

EID: 0037764684     PISSN: 13518216     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2516.9.s1.16.x     Document Type: Article

References (12)

1. Nilsson IM, Berntorp E, Löfqvist T et al. Twenty-five years' experience of prophylactic treatment in severe haemophilia A and B. J Int Med 1992; 232: 25-32.
2. Petrini P, Blombäck M, Lindvall N. Prophylaxis with factor concentrates in preventing haemophilic arthropathy. Am J Paediatr Haematol Oncol 1991; 13: 280-7.
3. Astermark J, Petrini P, Tengbom L et al. Primary prophylaxis in severe haemophilia should be started early but can be individualised. Br J Haematol 1999; 105: 1109-13.
4. Petrini P. What factors should influence the dosage and interval of prophylactic treatment in patients with severe haemophilia A and B? Haemophilia 2001; 7: 99-102.
5. Ljung R, van den Berg M, Petrini P et al. Port-a-Cath usage in children with haemophilia: experience of 53 cases. Acta Paediatr 1998; 87: 1051-4.
6. Liesner RJ, Vora AJ, Hann IM et al. Use of central venous catheters in children with severe congenital coagulopathy. Br J Haematol 1995; 91: 203-7.
7. Meideros D, Miller KL, Rollins NK et al. Contrast venography in young haemophiliacs with implantable central venous access devices. Haemophilia 1998; 4: 10-5.
8. Kreutz W, Escuriola-Ettingshausen C, Funk M et al. When should prophylactic treatment in patients with haemophilia A and B start? The German experience. Haemophilia 1998; 4: 413-7.
9. Manco-Johnson MJ, Nuss R, Geraghty S et al. Results of secondary prophylaxis in children with severe haemophilia. Am J Haematol 1994; 47: 113-7.
10. Ehrenforth S, Kreutz W, Scharrer I et al. Incidence of development of factor VIII and IX inhibitors in haemophiliacs. Lancet 1992; 339: 594-8.
11. Scharrer I, Bray GL, Neutzling O. Incidence of inhibitors in haemophilia A patients - a review of recent studies of recombinant and plasma-derived factor VIII concentrates. Haemophilia 1999; 5: 145-54.
12. Warrier I, Ewenstein BM, Koerper MA et al. Factor IX inhibitors and anaphylaxis in haemophilia B. J Paediatr Haematol Oncol 1997; 19: 23-7.